First in man use for hemostatic sealant patch

Radboudumc and partners First in man use for hemostatic sealant patch

29 April 2021

Hemostatic sealant solutions innovator GATT Technologies announced today the successful first-in-man of its lead product GATT-Patch, used to resolve bleeding in a patient undergoing liver resection surgery by Radboud university medical center Nijmegen (Radboudumc).

Read the full story here

Related news items

First patient with systemic sclerosis treated with T-Guard Clinical study started with Philikos

20 May 2025 read more

First patient receives artificial lateral meniscus Clinical study on artificial lateral meniscus begins

23 March 2025 read more

Magnetics microrobots remove blood clots from sheep iliac artery

4 March 2025 read more

Funding for research into drug against systemic sclerosis Radboudumc Holding one of several investors in startup Philikos

19 December 2024 read more

ATRO Medical starts unique meniscus study

1 November 2024

As the first worldwide, ATRO Medical is starting a clinical study on the function of an artificial outer meniscus, the lateral meniscus. This is a first: never before has a removed lateral meniscus been replaced by a plastic specimen, the Artimis® Meniscus Prosthesis.

Radboudumc and ATRO Medical launch research on AI-generated artificial meniscus

1 July 2024 read more